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-- 
After early attempts at surgically ameliorating acquired 
heart valve lesions had faltered, renewed activity in the late 
1940*s led to perfection of techniques whereby surgeons began 
to achieve symptomatic relief and prolonged life in patients 
1-3 
with mitral stenosis. Initially, only hopelessly disabled 
patients refractory to all standard treatment received the 
operation, which involved a blind incision of the fused mitral 
commissures after surgically entering the left atrium. Even 
with respect to these gravely ill patients, investigators 
realized that certain features of their disease appeared to 
predict the likelihood of a good surgical result. As the 
operation was extended to those less severely affected, it 
became particularly important to learn what patients might be 
expected to benefit from such a major operation. 
Various groups sought to define specifically and objectively 
those clinical and laboratory parameters that enabled one to 
assess the desirability of surgery in a patient with mitral valve 
disease, and equally important, to assess the outcome by other 
than subjective means. Given the profound impairment suffered 
by these first few patients who volunteered for such pioneering 
surgery, there existed an understandable tendency for some who 
survived to exaggerate their symptomatic relief, making analysis 
of the surgical results difficult. 
Unfortunately, precise methods of evaluation were lacking, 
* 
as were criteria with which to interpret the results of 
whatever evaluation was undertaken. One group advised that 
preoperative screening should consist of "a careful clinical 
history and examination ... by an especially interested car¬ 
diologist,"2 Echoing this sentiment, another report stated 
that "it is obvious that the careful auscultatory examination 
by an experienced cardiologist is paramount.Although such 
careful examinations served the necessary function of documenting 
the existence of the disease that one sought to treat, it 
became clear that such maneuvers provided limited information 
and more elaborate means soon surfaced to delineate the nature 
of the cardiac disease and the prospects for surgical relief. 
With increasing surgical experience, surgeons discovered 
that operative relief could obtain only in those patients whose 
symptoms stemmed predominantly from a mechanical mitral "block," 
that is , a stenotic valve which obstructed flow. If other 
cardiac disorders, such as myocardial dysfunction, bacterial 
endocarditis, active rheumatic carditis, and mitral regurgita¬ 
tion, or non-cardiac factors contributed to the patient’s 
symptom complex, surgery offered little benefit and substantial 
risk. Hence, one tried to exclude the presence of these cardiac 
and non-cardiac factors in selecting patients for surgery. In 
addition to the history and physical examination, sometimes 
repeated throughout long periods of observation, blood cultures, 
electrocardiograms, standard chest roentgenograms, four-way 
radiologic views of the heart with barium swallow, and phono- 
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4-7 cardiograms were utilized in efforts at complete diagnosis. 
For example, left ventricular enlargement or hypertrophy documented 
by these methods implied additional cardiac defects, and reduced 
the probability that surgical correction of the mitral stenosis 
would yield a good outcome. 
Although one early observation held that intra-cardiac 
catheterization was possibly helpful in only "certain confusing 
o 
states of mitral stenosis," its use preoperatively became 
quickly established because of the additional valuable infor¬ 
mation it provided about the severity of a suspected mitral 
block. By performing right-sided catheterizations, one 
obtained pulmonary artery pressures and indirect left atrial 
pressures (by a pulmonary capillary wedge catheter). Studies 
had shown that patients with symptomatic mitral stenosis had 
varying degrees of pulmonary artery hypertension, abnormal rest¬ 
ing cardiac outputs, and abnormal cardiac output responses to 
exercise.9 Catheterization permitted quantitative measurements 
of these parameters, and furthermore, allowed pre- and post¬ 
operative comparisons by repeat cath study. In this way, 
researchers learned that post-op relief of symptoms generally 
correlated with a reduction in pulmonary pressures, although 
rarely did such pressures fall to a normal range. 
In screening candidates for operation, it was felt that 
surgery offered little relief to patients with no pulmonary 
hypertension, with or without aberrant cardiac outputs. In 
such cases, factors other than mitral block were thought to 
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be responsible for symptoms. Investigators sometimes 
employed acute digitilization of patients undergoing cathe¬ 
terization in order to discern whether myocardial insufficiency 
played a role in the production of abnormal pulmonary artery 
pressures and cardiac outputs.10 
One group advocated that study of the morphology of the 
indirect left atrial pressure curve yielded further informa¬ 
tion about the presence of mitral regurgitation complicating 
mitral stenosis. Excessive regurgitation precluded surgical 
repair of the valve. Others criticized the value of pressure 
curve analysis.11* 12 
Despite these advances in identifying more precisely those 
factors relevant to an evaluation of the suspected stenosis, 
certain problems remained. One problem was that hemodynamic 
measurements at cath reflected the particular physiologic state 
of the patient at that moment in time, and did not necessarily 
bear a relationship to the hemodynamic status of the patient 
when he was symptomatic, or at another time when the catheteri¬ 
zation was repeated. In other words, the degree of pulmonary 
hypertension not only depended on the existence of some pathol¬ 
ogy, but also on the uncharacterized and uncontrolled inotropic, 
chronotropic, and vascular tonal influences present at a given 
time. Did an anxious patient with a heart rate of 120 and a 
mean pulmonary artery pressure of 30 mm Hg have a more severe 
block than a patient with a rate of 75 and a pressure of 25 mm Hg? 
Furthermore, as investigators noted, pulmonary hypertension did 
4 
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not specify mitral stenosis, but potentially resulted from 
other lesions as well. Even if one was certain that a mitral 
block alone produced the pulmonary hypertension, the correla¬ 
tion between the pressure measured and the severity of the 
stenosis was uncertain. As already pointed out for example, 
pulmonary hypertension persisted in those patients who 
experienced subjective relief with comraisurotomy, albeit usu¬ 
ally at a reduced level. 
Preoperative evaluation of these patients was satisfac¬ 
torily refined when it became possible to measure the actual 
area of the stenotic valve. Borrowing principles from hydraulic 
engineering, Gorlin and Gorlin developed a method permitting a 
quantitative assessment of the severity of stenotic valve lesions. 
By concentrating on the valve are^ these authors focused on 
the essential problem of obstruction to flow, rather than on 
variable effects secondary to the obstruction such as pul¬ 
monary hypertension.1^ 
Their initial insight into the problem was that the non- 
laminar flow through a valve was inadequately described by 
Poisseuille's Law : Flow = (Pressure Gradient)(Radius 
(Length)(Fluid Viscosity) 
Hydraulic considerations suggested that flow through a valve was 
more closely approximated by Torricelli's orifice equation: 
Flow = Cc»A*V, Where A is the orificial area, V is the flow 
velocity, and Cc is the coefficient of contraction, a constant. 
A second applicable physical principle stated that the square 
of the flow velocity, = Cv2*2»gh, where g is gravitational 
5 
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acceleration, 980cm/sec2, h is the pressure gradient, and 
Cv2 is the coefficient of velocity, a constant. Rearranging 
the two equations and solving for area yielded a.formula for 
valve area: Area = Valve Plow = Valve Flow 
Cc*Cv2V2&h 44,5.C^H 
where C = Cc»Cv2# 
To use the formula for mitral valve calculations, valve flow 
was based on an adjustment of cardiac output which reflected 
■fdCt 
theAthat mitral valve flow was a diastolic event. Hence, 
mitral valve flow (in ml/sec) = cardiac output in ml/min 
divided by the diastolic filling period (DFP) in sec/min. 
Gorlin and coworkers then applied this hydraulic formula 
to the intact heart. Routine catheterization techniques of the 
time did not include direct measurement of left heart pressures, 
and so the DFP was estimated from the systolic ejection time, 
SEP (DFP = 60 - SEP), This produced a slightly exaggerated 
value for DFP, since it incorporated both the systolic iso- 
volumic phases as well as the diastolic filling period. 
Furthermore, pressure gradients across the mitral valve were 
approximated as the difference between the mean pulmonary 
capillary wedge pressure as an indirect measurement of left 
atrial pressure, and 5 mm Hg, a number chosen to represent 
the average left ventricular diastolic pressure. Given these 
assumptions, it was found through testing of surgical and au¬ 
topsy specimens that the proper constant needed to determine the 
mitral valve area (C) was 0.7. 
Further studies explored the application of the formula 
6 
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to the stenotic aortic valve, although at the time, surgical 
correction of that lesion had not proved nearly as successful 
as the mitral operation.^ When aortic valve flow (com¬ 
puted as the cardiac output divided by the systolic ejection 
period) and aortic valve gradients were inserted into the 
formula, the proper constant for area calculation was found 
to be 1.0.15 
Gorlin and colleagues cogently demonstrated how their 
particular analysis more readily defined the clinical severity 
of stenotic lesions and the possible benefits of surgery than 
the methods suggested by others. Studies had shown 
that symptoms attributable to mitral stenosis included those 
resultant from high left atrial pressures, inducing pulmonary 
hypertension, and diminished caridac output05*6,9, 1® 
Because of the mitral block, the transvalvular gradient 
needed to produce flow across the valve resulted in an ele¬ 
vated left atrial pressure, manifesting itself as dyspnea 
secondary to pulmonary congestion, or worse, as pulmonary 
edema. Later in the course, right heart deterioration resulted 
from the increased pulmonary resistance. Patients also experi¬ 
enced exercise intolerance or easy fatiguability as a result 
of abnormal cardiac outputs at rest and/or on attempted exercise. 
Although one could measure both outputs and left atrial pressures 
at catheterization, one still needed to know how to interpret 
these data. 




their inter-relationship, which other researchers had failed 
to make use of in their analyses.'. No matter what the patient's 
inotropic and chronotropic state, the level of peripheral 
vascular resistance, or the degree of primary myocardial 
disease, he existed hemodynamically at a point of a curve 
described by the formula, which allowed only certain pairings 
of pressures with cardiac outputs at a given valve area. This 
invariable relationship provided the key >with which to 
understand for example, whether a patient with a low normal 
cardiac output of 3.0 1/min had a clinically more severe lesion 
than a patient with an output of 4.0 1/min. 
The Gorlin formula demonstrated that any compensatory 
mechanism operating in vivo which decreased pathologic left¬ 
sided pressures also had to lower cardiac output, the valve flow 
time - period or both. Inversely, any increase in cardiac 
output reflected in increased valve flow, as might be induced 
with exercise, necessitated a rise in those pressures. Thus, 
in a particular patient, the formula explained how the normal 
) be.e-n 
cardiac output obtained at cath may haveApossible only at the 
price of an elevated mitral valve gradient. Similarly, a 
particular patient with severe mitral stenosis might have been 
found to have a relatively normal left atrial pressure by main¬ 
tenance of a low cardiac output. 
Therefore, the formula emphasized that it was the fixed 
relationship of flows to gradients and not the flows and gradients 
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summarized by the valve area, which was a function of both 
parameters. Gorlin and coworkers then proceeded to define on 
physiologic grounds what lesions constituted clinically severe 
disease and merited operative relief. As illustrated in 
Figures 1 and 2, a given valve area generated a specific pressure- 
flow curve. Examining these graphs, Gorlin and colleagues 
recognized that at "critical" areas, the curves flattened. 
A flat region of the curve implied that any increase in 
transvalvular pressure, large or small, brought about only a 
relatively minimal increase in flow. Indeed, even to produce 
minimal increments in flow, large increases in pressure were 
necessary. For the mitral valve, this adverse situation obtained 
at about 1.0 to 1.2 cm2 or less; similarly for the aortic valve, 
at about 0.5 to 0.6 cm2. 
At these critical areas, any increased demand on cardiac 
performance invariably exacted a high price, even if resting 
values measured at catheterization suggested only slightly aber¬ 
rant hemodynamic parameters, and one could predict a severe 
functional impairment. For example, one could see that a rest¬ 
ing wedge pressure of 15 mm Hg was possible in a patient with 
a MVA (mitral valve area) of only 1.0 cm2, but only if his 
mitral valve flow (MVF) was 100 ml/sec, which might correspond 
to a low cardiac output of 2.5 1/min. Yet merely to double that 
MVF required a lengthening of the DFP (and tha*eby required a 
decreased SEP) and/or as much as a quadrupling of the wedge 
pressure (to a dangerous 60 mm Hg). One did not actually have to 
9 
. 
record these forbidding observations at catheterization to 
know that (^ese relationships held. On the other hand, a 
patient with a valve area of 2.0 cm2 could have had a higher 
MVF of 200 ml/sec with the same wedge pressure of 15 mm Hg. 
The functional impairment induced by this patient's stenosis 
was obviously much less. Indeed, he might have been able to 
treble the MVF of 100 ml/sec before experiencing any respira¬ 
tory difficulties (a MVF of 300 ml/sec would yield a left 
atrial pressure gradient of about 26 mm Hg). One expected 
the first patient to benefit much more from a surgical pro- 
1 7 
cedure than the second. ' 
Although the mechanics of myocardial compromise were 
somewhat different in aortic stenosis (involving symptoms 
secondary to left ventricular hypertrophy and inadequacy of 
to , 
myocardial oxygenation, as well asApulmonary congestion), 
similar considerations argued for the utility of the critical 
aortic valve area in selecting patients for aortic valve 
replacement when that operation became available. 
The theoretical advantages of the Gorlin approach were clear, 
but was the formula reliable? Did hydraulic principles prove 
to be adaptable to living systems? Gorlin and Gorlin noted 
13 
some of the theoretical problems with their equation. J 
For example, the equations used to derive the formula were 
best applicable to constant velocity flow, not the pulsatile 
flow of blood. Furthermore, the turbulence generated in 






Cc and Cy2, each in different directions. Finally, as noted 
above some of the parameters to be plugged into the formula 
could not even be measured, but were estimated (i,e., gradient 
and DFP). Nonetheless, Gorlin and Gorlin found agreement 
between the calculated valve area and empirically determined 
valve area in three of eleven patients; five calculated areas 
exceeded measured valve areas by 0,1 cm2, and three calcula- 
ted areas were 0.1 to 0.2 cm less than empirically deter¬ 
mined valve areas.*3 
Examining the equation by means of a theoretical model, 
Rodrigo added that even the actual orifice area and the cross- 
sectional areas of the chambers emptying into and draining the 
orifice influenced the accuracy of the formula, factors not 
appraised in calculating valve area. Yet he basically affirmed 
that the formula held for the conditions which pertained to 
18 
human subjects undergoing catheterization. 
There have been subsequent critical comments concerning 
the formula, suggesting that it could be made more precise by 
modifying the valve constant to reflect current cath techniques 
which no longer require estimations of DFP and gradients.» 20 
The proposed modification has been a minor one and has not 
directly borne on the matter of the consistency of the formula 
when applied to a variety of hemodynamic settings, since it has 
concerned the constant, not the dependent variables. 
Certain technical problems have remained with respect 
to the effects of cath-derived data on the validity 
11 
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of the formula. The accuracy of the formula has of course 
absolutely depended on the ability to measure the necessary 
hemodynamic parameters precisely. Has random or systematic 
error in catheterization measurements, consequent of the 
way in which flows and gradients were recorded, posed an obsta¬ 
cle to the precision of valve area calculations? Have the 
low recorded flows and gradients, as sometimes found in valvu¬ 
lar heart disease particularly lent themselves to distortion 
of calculated areas?2* Because the Gorlin formula incorpo¬ 
rated a mathematical division, a small error in the denominator 
(i.e,, the gradient determined at cath) potentially created a 
large error in the valve area. 
For example, a patient with a mitral valve gradient (MVG) 
of only 6 mm Hg and a mitraljyalve flow of 137 ml/sec could have 
a MVA of 1.8 cm2. An error in gradient measurement of a mere 
7.5 mm Hg, yielding a MVG of 13.5 mm Hg (6 + 7.5 = 13.5), 
would have resulted in a calculated critical valve area of 1.2 
cm2. Another illustration - if a patient's MVF equals 90 ml/sec 
and MVG 2mm Hg, one calculates a MVA of 2.1 cm2. Yet a slight 
imprecision in MVG measurement yielding a value of 6 mm Hg, 
a difference of only 4 mm Hg, would have given a critical area 
of 1.2 cm2. 
Another technical problem in utilizing the formula has 
concerned the accuracy of transva^lvular flow determinations. 
The method employed for cardiac output measurement (described 
in further detail in the Methods and Materials section), the 
12 

direct Pick oxygen consumption technique, is based on the 
following: Cardiac Output = Total Body Oxygen Consumption ^22^ 
arterial O2 content - mixed venous O2 content 
In other words, because of its role in distributing oxygen 
to oxygen consuming tissues?of the body, one is able to de¬ 
duce the total cardiac flow from knowing the total oxygen con¬ 
sumption and the arterio-venous oxygen difference. The method 
itself has been reproducible in a given patient ±1C$, a 
variability unlikely to cause significant imprecision in the 
calculated valve area.22>23 However, a problem has arisen in 
patients with left heart regurgitant lesions as well as ste¬ 
nosis, because in these patients, the Pick method has under-* 
estimated transvalvular flow to a degree depending on the severity 
of the regurgitation. The inadequacy of the output method in 
these patients has stemmed from the fact that the Pick 
principle measured only that fraction of total oxygen carrying 
blood flow supplying the body's oxygen consuming tissues. This 
oxygen is contained in the blood ejected from the left heart 
(the forward flow). In the setting of regurgitant lesions, part 
of total left ventricular oxygen carrying flow never leaves the 
heart to reach oxygen consuming tissues, but regurgitates back 
into the heart (regurgitant flow). Hence, the Fick method 
measures only forward flow, but in patients with regurgitant 
lesions, transvalvular flow depends on the sum of forward and 
regurgitant flow. To illustrate, a patient has mitral stenosis 




the mitral valve, enters the left ventricle, and leaves 
this chamber during systolic contraction. During diastole, 
a fraction of this blood drains back into the left ventricle, 
the rest continuing forward to perfuse the body. The Fick 
method measures only this forward fraction. One can see that 
the total transvalvular flow has consisted of both blood 
flowing forward and regurgitating through the aortic valve. 
Therefore, the Fick method underestimates the transvalvular 
flow, and the greater the regurgitation, the greater the under¬ 
estimation. This incorrectly small flow determination is then 
used in the numerator of the Gorlin formula to yield an incor¬ 
rectly small valve area. 
Despite this difficulty, the formula has still proved 
useful in the evaluation of patients with mixed stenotic and 
regurgitant lesions. Because the error in flow determination 
always occurs as an underestimation, one can still calculate 
a minimum effective valve area, that is, an area indicating 
the smallest possible orifice size in a given patient, recog¬ 
nizing that the area could be even larger. Even in the setting 
of regurgitation, if calculated valve area exceeds the critical 
value, one could eliminate the stenosis as a likely cause of 
symptoms amenable to surgical correction (whetheb the regur¬ 
gitation itself warranted surgical attention became a matter of 
greater diagnostic concern in the 1960's when valve replacements 
became available2^*2^). 
A final problem in the application of the formula has 
14 
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centered on mitral valve gradients recorded in patients with 
aortic regurgitation.2^"2^ With the anatomic juxtaposition 
of aortic outflow tract with mitral leaflets, the regur¬ 
gitation itself potentially contributed to the mitral valve 
gradients measured at catheterization. This may represent 
a functional obstruction to flow. However, in such a situ¬ 
ation, the calculated area overemphasizes the severity of 
a stenotic lesion involving the mitral valve, even creating 
the appearance of mitral stenosis when it does not exist in 
some cases. 
In an effort to mitigate some of the error-producing 
factors explored above, the practice of the Yale-New Haven 
Hospital catheterization laboratory has been to record a 
given patient's hemodynamic parameters in two physiologic 
states at the same catheterization - once at rest, and again 
during an intervention designed to increase flow rates across 
the valves. The interventions chosen, exercise via supine 
bicycle ergometry, or catecholamine infusion (isoproterenol 
or epinephrine) have been shown to increase cardiac outputs 
and also to influence the extent of backflow in patients with 
regurgitant lesions, through inotropic, chronotropic, and 
, 2<\. 23 30-47 
peripheral vascular effects . It was hoped that these 
interventions would therefore diminish imprecision generated 
J>y spurious variability around small gradients as discussed 





For example as shown previously, in a patient whose resting 
state MVF was 90 ml/sec, an error of 4 mm Hg in MVG measure- 
2 
ment yielded a change in MV A from 2.1 to 1.2 cm . A critical 
value. By stressing the patient and increasing the flow to 
291 ml/sec, one now generates a MVG of 20 mm Hg for a valve 
area of 2.1 cm2, Under these circumstances, in order to 
arrive at a miscalculated MVA of 1.2 dm2, one would have to 
err greatly in measuring the MVG - by 4l mm Hg instead of a 
mere 4 mm Hg, 
It was felt that errors secondary to the magnitude of 
a regurgitant fraction could be lessened if the effect of the 
intervention would be a diminution of the regurgitant fraction 
of total flow. 
With these considerations in mind, I shall review the 
experience of the Yale-New Haven Hospital catheterization 
laboratory in order to evaluate the accuracy and usefulness of 
the Gorlin formula in actual practice, and to assess whether 
exercise or catecholamine infusion has proven useful in 




Materials and Methods 
Twenty-eight catheterization reports involving 26 adult 
patients with left-heart valvular lesions were reandomly se¬ 
lected from the period 1971-77 for retrospective analysis. 
Patients underwent catheterization to document the presence 
and severity of valvular lesions identified clinically. The 
general protocol foxr this procedure involved sedation prior 
to the performance of right-sided (by vein) and left-sided 
(by retrograde arterial cannulation) heart catheterization 
via brachial and/or femoral routes. Pressures were determined 
by fluid-filled catheters with a frequency response of 25 Hz 
connected to Statham P23 Db transducers balanced at zero 
pressure by opening to atmospheric pressure. The zero pressure 
reference point was taken to be mid-chest. Pressures were then 
electronically calibrated on an Electronics for Medicine DR-8 
recorder (Electronics for Medicine, White Plains, N.Y.) before 
and after each series of pressure tracings. 
Measurement of left atrial pressure was achieved by placement 
of a catheter in the pulmonary capillary wedge position. For 
the purpose of determining mitral valve gradients (MVG), 
pressures from wedge and left ventricular catheters were re¬ 
corded simultaneously on photographic paper.moving at 100 mm/sec. 
In those patinnts with aortic stenosis, aortic valve gradients 
(AVG) were obtained by simultaneous recording of left ventricu¬ 




Besting cardiac outputs were obtained in the majority of 
cases via the direct Fick oxygen consumption method, using 
a three minute air collection period at the same time, or 
within several minutes of the recording of pressure gradients. 
According to the Fick equation: Cardiac Output = O2 consumption 
divided by arteriovenous oxygen difference. Oxygen consumption 
was determined by having the patient breathe into a Douglas 
bag while recording the volume expired during the collection 
period by a Tissot spirometer. The volume of expired air was 
corrected to standard dry conditions of pressure and temperature 
(corrections tables are widely available; for example see ref¬ 
erence 48)• Oxygen and carbon dioxide content of expired air 
was analyzed in a device employing the Scholander technique 
(Otto K. Hebei Scientific Instruments, Rutledge, Pa.) Arterio¬ 
venous sampling was at the pulmonary artery and a systemic artery 
with oxygen content analysis performed on a Lex-02-Con oxygen 
analyzer (Lexington Instruments Corpc, Waltham, Mass.) During 
the intervention state (either exercise or catecholamine infusion), 
the air collection period varied from one to three minutes, 
during a time when hemodynamic state had stabilized. In a few 
cases, outputs were measured by the indocyanine green dilution 
method.22 
Six patients bicycled in the supine position, during 
which time pressure and output studies were completed. Patients 
with aortic stenosis were not considered candidates for this 




epinephrine drip at a rate of two to four mcg/min. Simi¬ 
larly, twelve patients a two to four mcg/min infusion of 
isoproterenol. 
Following an intervention, left ventriculograms, aorto- 
graras, and coronary arteriography (in most patients) were 
performed using standard techniques and were recorded on 35 mm 
cine film. Valvular regurgitation was assessed according to 
the criteria of Sellers, et al: 1+ indicated a puff of injec¬ 
ted radio-opaque contrast material traversed a valve during its 
closure period, with rapid clearing of the contrast material 
subsequetnly; 2+ indicated faint opacification of the entire 
chamber proximal to the valve (atrium or ventricle) with rapid 
clearing; 3+ indicated opacification of equal degree on both 
sides of the valve, occurring immediately after injection; 
and 4+ indicated greater opacification proximal to the valve 
50 
than distal. Regurgitation of 1+ was considered insignificant, 
and for the purpose of this study patients with 1+ regurgi¬ 
tation and stenosis were grouped with those with pure stenosis. 
Throughout the cath procedure, patients were monitored with a 
Lead II electrocardiogram, recorded simultaneously with the 
pressure tracings. 
Valve areas were computed by the Gorlin formula (see 
Figure 3). Heart rate was determined from the electro¬ 
cardiogram over five or ten cycles depending on the regularity 
of the rhythm (five for sinus rhythm). Diastolic filling 






section of the pulmonary capillary wedge tracing (PCW) with 
the upstroke and downstroke of the left ventricular pressure 
curve. Similarly, the systolic ejection period (sec/beat) 
was determined by measuring the time distance between the 
intersection of the systemic pressure curve with the simulta¬ 
neously plotted left ventricular pressure curve. 
Pressure gradients were calculated by hand digitization 
over 40 millisecond intervals (time lines provided by the 
photographic recorder) and at pressure sensitivities of 0 to 
40 mm Hg for the mitral valve and 0 to 200 mm Hg for the 
aortic valve. Mean pressures were obtained by electronic 
damping of the pressure signals. Gradients, heart rates, 
and flow periods were averaged over five cardiac cycles for 
patients in sinus rhythm, or over 10 cycles in patients with 
atrial fibrillation or sinus rhythm with ectopy. Extraction 
of data from pressure tracings was performed by members of 
the Section of Cardiology at the time of catheterization. 
For the purposes of this study, I reviewed all data for 
accuracy and recalculated information as indicated. 
Mean systemic pressure in mm Hg, right atrial pressure 
in mm Hg, and cardiac output were utilized to compute 
total systemic vascular resistance (TSVR): TSVR in 
dynes•sec*cm“5 = systemic - right atrial pressure x ^ 
cardiac output (1/min) 
Prior to angiography, left ventricular end-diastolic pressure 
(LVEDP) was measured at high sensitivity (0 to 40 mm Hg scale) 
and recorded as the pressure at the end of the left ventricular 
20 
•- 
VALVE AREA = Transvalvular Flow_ 
C x 44.5-^Pressure Gradient 
Mitral valve flow (MVF) = Cardiac Output fol/min)/Diastolic Filling 
Period 
Diastolic Filling Period = diastolic filling period (sec/beat) x HR 
HR = heart rate (beats/min) 
Aortic valve flow (AVF) = Cardiac Output (ml/min)/SEP 
Systolic Ejection Period (SEP) = systolic ejection period (sec/beat) 
x HR 
For the mitral valve, C = 0.7. For the aortic valve, C = 1.0. 
Figure 3 
.* 
a wave, or when the a wave was not present, as the pressure 
forty milliseconds after the onset of the QRS complex on the 
electrocardiogram. 
Patients have be01 grouped into six categories: 
pure mitral stenosis; pure aortic stenosis with or without 
associated mitral stenosis; mitral stenosis, including those 
with associated aortic stenosis; mitral stenosis and mitral 
regurgitation; mitral stenosis with aortic regurgitation; 
mitral stenosis with aortic or mitral regurgitation. The 
magnitude of change of valvular areas measured in two 
different states has been defined as the difference between 
resting and intervention valve areas divided by resting valve 
areas. Statistical analysis of data has been performed using 
paired two-tailed t-tests. Results have been considered 
significant for a level of probability (p) less than 0.05. 
S 2 





Table I presents the data available on sixteen patients 
whose catheterization studies documented mitral stenosis (MS) 
as the predominant left-sided lesion. One patient (WE) had 
severe tricuspid regurgitation but was included because right¬ 
sided regurgitation did not interfere with the mitral valve 
flow determination. Patients ranged in age from 21 to 64, and 
all were female. Because of the small number of patients 
involved, resting state values were compared to intervention 
state Values, without differentiation between catecholamine 
infusion or exercise for the purpose of the paired t-test 
analysis. 
Mean cardiac outputs increased from 4.1±2.0 to 6.6*3.8 
1/min (p=3.4xl0“3) from resting to intervention state. In 
the twelve patients evaluated, oxygen consumption increased 
from 158±34 to 260±156 ml/min (p=3.8xl0-2). Heart rate rose 
from 8l±l4 to 128±28 beats/min (p=3.0x10-6). Data needed to 
calculate TSVR were available in only three patients, all of 
whom received isoproterenol. In all cases, TSVR declined with 
the infusion. The diastolic filling period remained essentially 
stable, but the mitral valve flow rose from 153*89 to 233*124 
ml/sec (p=l.4x10-3). Pulmonary capillary wedge pressures 
changed from l4±5 to 25±9 mm Hg (p=3.8xl0-6), and the MVG 
approximately doubled, 8.1*3.3 to 16.6*5.7 mm Hg (p=l.4x10-6). 





Mitral valve areas calculated at rest ranged from 
0.5 cm2 to 5.1 cm2 (mean 1.8±1,1 cm2). Intervention MVAs 
ranged from 0.5 to 4.4 cm2 (mean 2.0^1.1 cm2). Resting 
and intervention valve areas did not differ significantly 
by paired analysis. The magnitude of change ranged from 
0 to 0.57. Pour patients had no change in MVA. In six, 
valve areas rose (increments of 0,2 to 1.6 cm2), and in five, 
valve areas declined (decrements 0.1 to 0.8 cm2), of the 
eleven pairs of MVAs exhibiting a change, areas varied by 0.2 
cm2 or less in five. 
MVAs changed from critical to non-critical values in 
only one case (KJ), Despited this cross-over, this patient 
underwent operation, for unclear reasons. At operation, her 
lesion was simply described as “tight." In addition, patient 
MB underwent closed mitral commisurotomy, although both cal¬ 
culated MVAs were non-critical values. Favoring an operative 
approach despite these data was this patient's recurrent 
episodes of pulmonary edema. The surgeons found a slightly 
stenotic valve not admitting the tip of the index finger, to 
paraphrase their report. 
Altogether, three patients underwent closed mitral 
commisurotomy, one patient had an open mitral commisurotomy, 
and one patient had placement of prosthetic mitral and tri¬ 
cuspid valves. In their operative reports, surgeons only 
roughly assessed the degree of stenosis, describing valve areas 
in terms of fingertips or in one case, in terms of centimeters 
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of diameter. These crude but direct assessments did not 
permit a precise appraisal of the accuracy of the catheter¬ 
ization determined areas, although stenosis was found in each 
case. 
Aortic Stenosis 
Table II concerns three patients with aortic stenosis, 
one of whom had concomitant mitral stenosis (JC) and was 
studied on two separate occasions. At the time of catheteri¬ 
zation, patients' ages ranged from 45 to 64 years. All were 
male. 
Mean cardiac output climbed from 6.0*1.9 to 9.9*4.5 1/min 
with interventions (consisting of epinephrine infusion in 
three instances, and isoproterenol in one). As in the isolated 
MS group, certain parameters increased: oxygen consumption 
from 350±i6l to 377*113 ml/min, heart rate from 66±8 to 85±8 
beats/min, valve flow, from 310±u8 to 464±217 ml/sec, PCW, 
from 18±2 to 26±2 mm Hg, aortic valve gradient, from 24±n to 
39*19 mm Hg. Except for PCW (p=0.02), these increases did not 
achieve statistical significance, given the small numbers of 
patients studied. 
Systolic ejection period rose slightly, from 19.6*1.1 
to 21.6±3.4 sec/min, left vei&icular systolid pressure increased 
from 155-22 to 196±26 mm Hg, but mean systemic pressure appeared 
stable. Left ventricular end-diastolic pressures also increased 
slightly in most patients (from 19*6 to 25*n mm Hg). 
24 
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Changes in hemodynamic parameters were of a magnitude 
sufficient to achieve statistical significance in only two 
other areas - TSVR and AVA. Total systemic vascular resis¬ 
tance declined from 1150-381 to 802-404 dynes• sec*cm“-5 
(p=l.7xlO”3)# Aortic valve area increased in every patient 
(increments from 0.1 to 0.3 cm2, giving a magnitude of change 
ranging from 0.07 to 0.25). Mean AVAs were 1.6±0.9 cm2 at 
rest and 1.8±0.9 cm2 during intervention (p=l.6xl0-2). 
Separating patients with isolated (pure) aortic stenosis 
(patients LP and RD) from the others, one sees the same kinds 
of changes evident in the mean data as in the whole group 
(bottom, Table IIA). All calculated AVAs represented non- 
critical values. 
Two patients subsequently underwent cardiac surgery, one 
receiving a coronary artery bypass graft and an aortic valve 
replacement, the other, aortic and mitral valve replacements. 
The latter patient had concomitant MS with a critical resting 
MVA of 1,2 cm2. Operative findings were not phrased in such 
a way as to permit appraisal of the precise accuracy of the 
valve area calculations, but no gross discordance became mani¬ 
fest. Of importance is that in three instances of increased 
AVA, no regurgitation was demonstrated angiographically. There¬ 
fore, flow error secondary to regurgitation was unlikely to have 
contributed to the valve area increases. 
As indicated in Table IIB. one patient with AS was studied 




falling to 1.4 cm2 with epinephrine infusion (first catheteri¬ 
zation), and 1.2 cm2 rising to 1.6 cm2 (second cath), giving 
a megiitude of change of 0.13 and 0.33 respectively. Pertinent 
data have been included with values from Table IA, patients 
with isolated MS, and analyzed (Table III). Changes of a 
direction similar to those of Table IA were evident, with the 
persistent result that MVAs did not change from resting to 
intervention states in a statistically significant way. 
However, the addition of an extra pair of values for TSVR 
accorded significance (p=0.04) to the group decline of 1840 
*882 to 1443*868 dynes•sec.cm-5. 
Mitral Stenosis and Regurgitation 
Table IV consists of data collected from three patients 
with MS and concomitant 2 to 3+ mitral regurgitation (MR). 
Two females and one male comprised the study group, with 
ages ranging from 29 to 55 years. Sample size was too small 
for statistical significance to be demonstrated, but mean 
cardiac output (4.2*1.4 to 8.3*5.0 1/min), oxygen consumption 
(218*35 to 581*433 ml/min), DFP (30.4*1.2 to 35.2*8.2 sec/min), 
MVF (138*50 to 284*251 ml/sec), PCW (13±5 to 18*8 mm Hg), KVG 
(6.6*2.7 to 14.8*8.6 mm Hg), and heart rate (?4*10 to 91*22 
beats/min) all increased. Left ventricular end-diastolic 
pressure declined slightly (11*8 to 7*3 mm Hg). Mean MVA 
(l.9*0.9 cm2) rose with the interventions (to 2.2*1.3 cm2). 




0.31 and. 0.12), with the remaining area holding constant. 
No cross-overs from critical to non-critical areas occurred 
on repeat measurement. 
Two patients underwent operative treatment, one receiving 
a mitral valve replacement, the other mitral and aortic valve 
replacements. Apparent discrepancies between pre-operative 
assessments of the cardiac lesions and operative findings 
were identified in both cases. AS was noted to have severe 
aortic regurgitation while-on heart-lung bypass, although 
angiography had indicated only trivial aortic regurgitation. 
SG had calculated MVAs and a cardiac echo indicative of only 
moderate mitral stenosis; yet the surgeons reported that 
a stenotic valve with a 1 cm diameter (yielding an area of 
approximately 0.8 cm2 if one assumes area = (tf)(radius)2) was 
present on direct inspection. 
Mitral Stenosis and Aortic Regurgitation 
Table VA presents the data collected on five patients 
(four females, one male) with catheterization findings con¬ 
sistent with mitral stenosis and aortic regurgitation. One 
patient had aortic stenosis as well (VH). Ages of these subjects 
ranged from 27 to 65. All patients received catecholamine 
infusions during intervention measurements (four had isopro¬ 
terenol, one had epinephrine). As in other patient groups, 
cardiac outputs, heart rates, mitral valve flows, systolic 







intervention (3.^*1.1 to 8.8*7.0 1/min, 79*13 to 126*26 
beats/min, 108*38 to 275*179 ml/sec, 142*17 to 153*^0 mm Hg, 
and 78^18 to 92*22 mm Hg respectively). Changes were statis¬ 
tically significant for heart rate only. In addition, total 
systemic vascular resistance, oxygen consumption (data available 
in only two patients), and left ventricular end-diastolic 
pressures declined (1977*5^ to 1023*826 dynes• sec•cm”-5, 
185*115 to 142*38 ml/min, 13*6 to 5*3 mm Hg respectively). 
Changes were statistically significant for TSVR (p=0,047) 
and LVEDP (p=0.0l9). Diastolic filling periods and pulmonary 
capillary wedge pressures remained stable (32.5*7.2 sec/min to 
31.7^4.0 sec/min and 17*8 to 15*5 mm Hg respectively). 
Resting MVA ranged from 0.6 to 2.3 cm2, averaging 1.4*0.7 
cm2. With intervention, mean~r§se to 3.2*3.5 cm2 (range of 
individual values 0.9 to 9.4 cm2). These changes represented 
magnitudes of change ranging from 0 to l4.6. However, the 
increase in mean MVA was not statistically significant. Valve 
/ 
areas crossed from critical to non-critical values in two 
patients (HE and SP), and remained stable in two. One patient 
whose valve area crossed over did not undergo subsequent opera¬ 
tion (SP), while HE received surgical therapy to correct his 
severe aortic regurgitation. At operation, his mitral valve 
was normal, despite the preoperative calculated MVA of 0.6 cm2 
at rest. 
Two other patients received surgical relief. DM under¬ 




on direct examination. Patient VH underwent aortic valve 
replacement of her critically stenotic aortic valve. Her 
angiographically moderately severe aortic regurgitation was 
verified at operation. However, despite calculated MVAs 
at rest and intervention consistent with moderate mitral 
stenosis, surgeons found no mitral lesion. 
Mitral Stenosis and Left-sided Regurgitation 
Table VI presents an analysis of all seven pairs of 
rest-intervention MVAs in patients with associated aortic and/ 
or mitral regurgitation. Although mean valve area increased 
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TABLE IB - MITRAL STENOSIS 
GC 46 y.o. F. Hx RP, age 11. S/P two previous mitral commisur- 
otomies (last, five years prior to this cath). Sx: exertional 
chest pain, dyspnea on exertion, EKG - NSR, Angio: no regurgi¬ 
tation, significant CAD. No operation subsequent to cath as of 
5/77,(1.7 yrs, post cath). 
AL 64 y.o. F. S/P mit. commis. (11 yrs. prior to this cath). 
Sx: increasing fatigue, dyspnea, chest heaviness. EKG - AF. 
Angio: 1+ MR; no CAD. No subsequent operation known. 
KJ 46 y.o F. Sx: PND x 1. EKG - AF. Angio: stiff, domed mitral 
valve; 1+ AR; no CAD. Op: open valvulotomy revealing ''tight" 
stenosis. Pressure tracings from cath not available for review. 
JC 37 y.o F. Hx RF, Sx: increasing dyspnea. EKG - NSR. Angio: 
no regurg.; no CAD. Op: closed mitral commisurotomy; valve 
diameter estimated at l cm. 
WE 6l y.o. F , carrying dx RHD. S/P mitral commisurotomy, twenty 
yrs, previous to cath. Sx: increasing fatigue, dyspnea on 
exertion. EKG - AF. Angio: trace MR, 1+ AR, 4+ TR; no sig. CAD 
Op: MVR, TVR with porcine heterografts; valve lesions not 
described in op note. 
S/P closed mit. commis. (3 yrs. prior to cath.) 
BJ 59 y.o. F. Hx RF.^ Sx: increasing dyspnea. Previous episodes 
of pulmonary edema; questionable hx of MI. EKG - AF. Angio: 
dyskinetic apex; 1+ AR: no CAD. No subsequent operation known 
(as of 3 yrs post cath). 
DL 62 y.o. F. Sx: dyspnea on exertion, orthopnea. EKG - NSR. 
Angio: trace AR; minor CAD. No subsequent opration known. 
p— 
AS 43 y.o. F, carrying dx RHD. S/P mit. commis. 6mos. prior to 
cath. Sx: persistent dyspnea on exertion and^fatigue. Angio: 
trace AR; no CAD. No subsequent op known. 
DL 50 y.o. F. Questionable hx RF. S/P mit. commis. 15 yrs. prior 
to cath. Sx: increasing fatigue, dyspnea on exertion. EKG - 
AF. Angio: no regurg. or CAD. No subsequent op known. 
PO 57 y.o. F. Hx RF, S/P mit. commis 10 yrs. prior to cath. 
Sx: dyspnea on exertion, chest pain. EKG - AF. Angio: severe 
CAD; no regurg. No known op as of 8 mos. post cath. 
JS 34 y.o. F. Hx RF. Sx: increasing fatigue, dyspnea on exertion, 
orthopnea, hemoptysis. Hx of pulmonary embolism in past. 
EKG - NSR. Angio: minimal MR occurring during extra-systoles, 
1+ AR; no CAD. No known op subsequent to cath. 
■ 
TABLE IB - MITRAL STENOSIS (CONTINUED) 
VK 34 y.o. Sx: decreased exercise tolerance, dyspnea on 
exertion. EKG - NSR. Angio: 1+ AH; no CAD. Op: closed 
mitral commisurotomy; valve admitted a fingertip. 
AG 58 y.o. P. Sx: mild fatigue. HxCHF responsive to medical 
therapy; hematuria (? stones). Referred for cath because of 
increasing liver size and right atrial size (on CXR) to eval¬ 
uate possible right ventricular failure. EKG - AF. Angio: 
not performed. No known op as of 3 yrs. post cath. 
JS 2? y.o. F. Hx RF. Sx: near-syncope, palpitations. EKG - 
NSR. Angio: minimal MR and AR; no CAD. No op recorded as 
of 6 yrs. post cath. 
hx of pulmonary 
MB 21 y.o. F. Sx: mild dyspnea on exertion and chest pain;'*' edema x 4 
EKG - NSR. Angio: no regurg; no CAD. Op: closed mitral 
commisurotomy revealing slightly stenotic valve not admitting 
tip of index finger. 
LH 28 y.o. F. Sx: dyspnea on exertion. Hx of pulmonary edema x 1. 
EKG - NSR alternating with low atrial rhythm. Angio: no re¬ 
gurg.; no CAD. No subsequent op known as of 1.5 yrs. post cath. 
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TABLE IIB - AORTIC STENOSIS 
LP 64 y.o F. Sx: increasing dyspnea, exertional chest pain. 
Hx of COPD. EKG - NSR. Angio: no regurg; moderate CAD; 
small left ventricular cavity with septal and papillary 
muscle hypertrophy. No subsequent op as of 4.5 yrs post cath 
BD 55 y.o. m. Sx: chest pain, dyspnea on exertion. Hx hyper¬ 
tension. EKG - NSR. Angio: no regurg; increased left 
ventricular size with normal ejection fraction; inferior wall 
akinesis; proximal right CAD and minimal left CAD, Op: CABG 
and AVR, revealing calcified, bicuspid aortic valve. 
JC 54 y.o. M. Hx RP. Sx: dizziness, headaches. EKG - NSR. 
Additional cath data: REST - 
MVG 12.4, DPP 29.0, MVP 176, MVA 1.6. INT - MVG l6.8, DFP 
33.6, MVF 179, MVA 1.4. Angio: no regurg; no CAD; ? cardi¬ 
omyopathy. 
JC 55 y.o. m ( same pt. as above, 1.8 yrs. later). Sx: dyspnea, 
fatigue, recent episode of pulmonary edema, complicated by 
onset of raoid AF. EKG - sinus rhythm. Additional cath 
data: REST - MVG 8, DFP 42.6, MVF 106, MVA 1.2. INT - 
MVG 17, DFP 4i.4, MVF 205, MVA 1.6. Angio: left ventricular 
hypertrophy, left atrial enlargement, trace pre-systolic 
mitral regurgitation and 1+ systolic mitral regurgitation, 
probable Type III aortic dissection. Op: AVR and MVR, 
revealing calcified valves. Valve diameters not described; 
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TABLE IVB - MITRAL STENOSIS AND REGURGITATION 
PT _____ 
orthopnea, palpitations, 
SG 29 y.o. F. Sx: dyspnea on exertion,'''decreased exercise 
• tolerance. EKG - NSR. Cardiac echo: E-F slope 22mm/sec 
(consistent with moderate stenosis); ejection fraction 80/. 
Angio: ejection fraction 40/, although technical adequacy 
of estimation questionable; 2+ MR; 1+ AR; aortic leaflets 
appeared thickened and domed. Op: MVR, revealing “about 
a 1 cm orifice“ and minimal to moderate mitral regurgita¬ 
tion. Presence of calcium not described at angio or at op. 
AS 55 y.o. M. Hx RF, Sx: orthopnea, PND, ankle edema. 
Hx cerebral embolism in past. EKG - sinus rhythm. Angio: 
2+ MR; 1+ AR; prominent papillary muscles; normal ejection 
fraction; no CAD. Op: AVR and MVR, revealing a large heart 
with 2500 ml/min estimated aortic regurg. while on heart- 
lung bypass. Valves not described. 
JS 32 y.o. F. Hx RF; S/P mitral commis. 8 yrs prior to cath. 
Sx: increasing fatigue, dyspnea on exertion. EKG - sinus 
rhythm. Angio: moderate MR, minimal AR; no CAD. No subse¬ 
quent op as of 5 yrs. post cath. 
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TABLE VB - MITRAL STENOSIS AND AORTIC REGURGITATION 
FT _ 
HE 65 y.o. M. Sx: dyspnea on exertion and at rest. Hx includes 
past episodes of embolization to ilio-femoral vessels. EKG - 
AF. Angio: enlarged left ventricular cavity; stiff appearing 
mitral valve; 1+ MR; 4+ AR; no CAD. Op; AVR for AR; mitral 
valve not described. 
DM 49 y0o. F. Hx RF. Sx: dyspnea, fatigue, palpitations. 
EKG - AF. Angio: trace MR; 2+ AR; no CAD. Op: closed 
mitral commisurotomy, revealing a mitral valve orifice barely 
admitting a finger; AR not assessed. 
SP 49 y.o. F. Hx RF. Sx: increasing dyspnea on exertion, orthop¬ 
nea, Carries dx of progressive systemic sclerosis. EKG - sinus 
rhythm. Angio: l+MR; 2+AR; no CAD. Ectopy present during 
resting pressure measurement. 
SG 27 y.o. F. Sx: increasing dyspnea, occasional ankle edema. 
EKG - sinus rhythm at rest; AF during isoproterenol infusion. 
Angio: mild to moderate AR. Pt. re-cath*ed two yrs. later 
and found to have 2+MR and 1+ AR (see Table IV). Earlier 
angio film not available for review. 
VH 51 y.o. F.~ Hx RF. Sx: progressive fatigue, dyspnea on 
exertion, intermittent pressing retrosternal pain. EKG - 
sinus rhythm. Additional cath data: REST - AVG 20, SEP 23.6 
AVF 119, AVA 0.5 INT - AVG 52, SEP 25.8, AVF 174, AVA 0.5. 
Angio: ejection fraction normal; 2+ MR; 2-3+ AR; decreased 
mitral valve mobility; 1-2+ left ventricular hypertrophy; 
doming, tricuspid aortic valve; no CAD. Op: AVR revealing 
a stenotic aortic valve but no mitral lesion; AR estimated at 
2 1/min during fibrillation. 
' 
TABLE VI - COMBINED MITRAL 









Legend for Tables I through VI 
Abbreviations: PT-patient; CO-cardiac output (liters/minute); 
V02 -oxygen consumption (milliliters/minute); HR-heart rate 
(beats/minute); TSVR-total systemic vascular resistance (dynes* 
sec*cm~^): DFP-diastolic filling period (seconds/minute); MVP- 
mitral valve flow (milliliters/sec); AVF-aortic valve flow 
(railliliters/sec); PCW-pulmonary capillary wedge pressure (mm 
Hg); MVG-mitral valve gradient (mm Hg); AVG-aortic valve gra- 
di*r\e/t (mm Hg); LVSP-left ventricular systolic pressure (mm Hg); 
DP-aiastolic pressure (mm Hg)* EDP-left ventricular end-diastol 
ic pressure (mm Hg); SP (MEAN)-systemic pressure (mm Hg); SEP- 
systolic ejection period (sec/minute); MVA-mitral valve area 
(cm2)* AVA-aortic valve area (cm2); R-resting state; Ex- 
exercise state; Is-isoproterenol infusion state; Ep-epinephrine 
infusion state; y.o.-year-old; F-female; M-male; Hx-history; 
RF-rheumatic fever; S/P-status post; Sx-symptoms; Angio- 
angiography; EKG-electrocardiogram; NSR-sinus rhythm; AR-aortic 
regurgitation; HR-mitral regurgitation; CAD-coronary artery 
disease; dx-diagnosis: AF-atrial fibrillation; RHD-rheumatic 
heart disease; Op-operation; PND-paroxysmal nocturnal dyspnea; 
MVR-mitral valve replacement; AVR-aortic valve replacement; 
TVR-tricuspic valve replacement; CHF-congestive heart failure; 
NA-not available, 
* Mean values were computed using data from patients in whom 
both resting (REST)and intervention (INT) studies were under¬ 
taken, since only paired values could be incorporated into the 
t-test. Hence, in Table IA, all l6 patients had both resting 
and intervention cardiac outputs, measured, and so means were 
based on data from all 16 patin^ts (as indicated.in the row 
marked Total Pairs), However,* for the category VO2, complete 
data v/ere available from both states in only 12 patients, and 
so only 12 pairs were used to calculate the means, P refers 
to statistical probability, NS indicates results Yvere not 
statistically significant, 
a Value shown represents LVSP, 
b Value shovm represents LVEDP. 





The present investigation has focused on the utility of 
the Gorlin formula in assessing the severity of valvular 
heart disease and the desirability of operative correction. 
Specifically looked at was the usefulness of repeating 
measurements after inducing hemodynamic stress in a given 
patient, either by infusing a catecholamine or having the 
patient exercise in the supine position. 
The interventions produced hemodynamic changes similar 
21,23,30-47 
to those reported by others . In all patient categories, 
mean cardiac output, heart rate, transvalvular gradients, and 
oxygen consumption (except in the Mitral Stenosis/Aortic Re¬ 
gurgitation group, where oxygen consumption was availafj^e in 
only tfo,j^ subjects) increased. Mean pulmonary capillary wedge 
pressures rose consistently in all except those with sig¬ 
nificant aortic regurgitation. Total systemic vascular 
resistance declined, consistent with the vasodilatory effect 
of the catecholamines employed in the small number of patients 
for whom data were available. Data were highly variable with 
respect to DFP and SEP, left ventricular systolic pressures, and 
left ventricular end-diastolic pressures. 
In the Mitral Stenosis group, valve areas varied in 
individual patients, but in l6 of 18 patients did not change 
from a critical to non-critical value. By statistical 
analysis, intervention areas did not differ significantly from 
resting values. This result confirms the consistency of the 
30 
- 
Gorlin formula when applied to patients with pure mitral 
stenosis in a variety of hemodynamic settings. In this 
study, repetition of hemodynamic measurements during an 
intervention state has not proven useful. 
In contrast to the Mitral Stenosis group, patients with 
aortic stenosis showed a small increase (0.2 cm2) in cal¬ 
culated AVA when hemodynamically stressed by catecholamine 
infusion. This interesting finding has been demonstrated 
in two other studies, both involving exercise as the inter¬ 
vention. In one group of eighteen patients with no or trace 
aortic regurgitation, mean AVA rose from 0.6 to 0.7 cm2 
(p=9.8xl0“? according to my calculations)^1. Thirteen of these 
patients experienced increase of 0.1 to 0.4 cm2 with six 
cross-overs from critical to non-critical values. In another 
group of 20 patients with isolate aortic stenosis, mean AVAs 
rose significantly from O.76 to 0.88 cm2 fp=8.2x10-5)^. 
Seventeen of 20 patients exhibited the rise (increments of 
0,06 to 0.34 cm^). Yet in only one case did the AVA change 
from critical to non-critical. In the present study, all 
patients had non-critical values recorded in both resting and 
intervention states; hence no cross-over occurred, suggesting 
that the small intervention increase is seldom clinically 
important. 
The fact that all AVAs in the present series were non- 
critical values raises a question about selection bias, and 










significance. According to considerations outlined in 
the introduction, possible sources of error in valve area 
calculations concern the presence of small gradients and the 
presence of regurgitation. It would be difficult to attribute 
the area increase to an error involving the intervention 
enlargement of small gradients and flows when the relatively 
smaller gradient and flows of the Mitral Stenosis group failed 
to produce a similar systematic increase in calculated valve 
area with intervention. As for the matter of regurgitation 
induced errors, in three of the four patients studied, angio¬ 
graphy failed to demonstrate regurgitation. 
Other studies in pediatric patients actually demonstrated 
statistically significant decreases in valve areas 
with catecholamine infusions, although one may criticize these 
studies on their failure to exclude subvalvular stenosis and 
their modification of the orifice equation-^*"-5^. The apparent 
increase in AVAs noted in the present study must remain unex¬ 
plained, but does not appear to be of a magnitude sufficient 
to alter the clinical interpretation of the severity of the 
stenosis. 
Underlying the use of catecholamines in the catheterization 
patients with documented regurgitation has been the hope 
that this kind of intervention would diminish the regurgitant 
fraction of total flow by increased inotropic and peripheral 
vasodilatory effects, thereby permitting more precise cal¬ 








in three patients with mitral stenosis and mitral regur¬ 
gitation, intervention did not prove useful,. No cross¬ 
over occurred between critical and non-critical values. 
More data for this group would be desirable 
However, in patients with mitral stenosis and aortic 
regurgitation, catecholamine infusion resulted in critical 
to non-critical valve area cross-overs in two of five patients. 
Patient HE experienced a dramatic rise in MVA, from 0.6 to 
9.4 cm^. At operation, no mitral lesion was noted; the re¬ 
corded resting MVG apparently resulted from the presence of 
severe aortic regurgitatinn impinging on the mitral valve 
apparatus. One might wonder if this patient's recorded 
intervention cardiac output was spuriously high, thereby 
accounting for the extreme increase in intervention MVA. How¬ 
ever, even a seven-fold error in cardiac output determination 
would have resulted in a valve area cross-over. 
The other patient with a valve area cross-over (SP) did 
not undergo surgery and despite numerous solicitations, did 
not make herself available for follow-up. Hence one can 
only speculate that the increase in calculated valve area 
was secondary to a redistribution of regurgitant flow. An 
additional patient with critical aortic stenosis (VH) experi¬ 
enced a reduction in mitral valve area despite an operative 
finding of a normal mitral valve. 
Thus, it appears that repeated hemodynamic measurements 





amine infusion) does add important information regarding 
the severity of the mitral lesion in some but not all 
patients with aortic regurgitation and resting mitral valve 
gradients. Unfortunately, data are insufficient to deline¬ 
ate which patients in this category of cardiac abnormalities 
at cath without mitral pathology at operation are likely 
to a calculated valve area increase with intervention. 
34 

Conclusion and Summary 
The experience of the Yale-New Haven catheterization 
laboratory in evaluating patients with left-sided valvular 
heart disease using the Gorlin formula for the calculation 
of areas of stenotic valves has been reviewed. Twenty-eight 
sets of data from 26 patients have been presented, and where 
applicable, compared to operative cases (11 cases). Specif¬ 
ically, data were analyzed to determine whether exercise or 
catecholamine infusion undertaken during the catheterization 
had clinically significant effects on the calculated areas 
of stenotic valves compared to values obtained during a 
resting state. 
In a group of 18 patients with mitral stenosis and no 
left-sided regurgitant lesions, the consistency of the Gorlin 
formula has been reaffirmed in varied hemodynamic settings. 
Although individual patients exhibited variations in valve 
areas between the resting and intervention states, the 
changes were not significant for the group as a whole. 
Cross-overs from critical to non-critical values occurred in 
only two patients, both of whom underwent operation in any case. 
Based on this result, one can conclude that repetition of 
hemodynamic measurement in this clinical setting does not 
appear to be useful. 
Similarly, in four patients with non-critical resting 
aortic stenosis, intervention measurements did not alter 





theless, a small but statistically significant increase in 
calculated areas occurred. This intervention induced area 
enlargement has been reported by others studying patients 
with aortic stenosis stressed with exercise. The basis for 
thPis enlargement is unclear, and more data will be necessary 
in order to reach a conclusion concerning the usefulness of 
intervention measurements in these patients. 
In patients with mitral stenosis and aortic regurgitation, 
ftS 
but not^mitral regurgitation, intervention measurements resulted 
in a reappraisal of the severity of a suspected mitral lesion 
in two patients, one of whom was found to have no mitral 
pathology at subsequent surgery. Intervention measurements appear 
to be worthwhile in helping to evaluate patients with aortic 
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